Similarly, other randomized controlled trials (RCTs) of TNF antagonists have not consistently demonstrated significant improvements in both enthesitis and peripheral arthritis for TNF-antagonist-treated patients compared with placebo-treated patients [10,12,14,16,17]. This evidence concerns the gene TNF and enthesitis.